NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
NL8300698A
(nl)
|
1983-02-24 |
1984-09-17 |
Univ Leiden |
Werkwijze voor het inbouwen van vreemd dna in het genoom van tweezaadlobbige planten; agrobacterium tumefaciens bacterien en werkwijze voor het produceren daarvan; planten en plantecellen met gewijzigde genetische eigenschappen; werkwijze voor het bereiden van chemische en/of farmaceutische produkten.
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
DK122686D0
(da)
|
1986-03-17 |
1986-03-17 |
Novo Industri As |
Fremstilling af proteiner
|
US5443826A
(en)
|
1988-08-02 |
1995-08-22 |
Borody; Thomas J. |
Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
|
KR100225087B1
(ko)
|
1990-03-23 |
1999-10-15 |
한스 발터라벤 |
피타아제의 식물내 발현
|
BR9106435A
(pt)
|
1990-05-09 |
1993-05-04 |
Novo Nordisk As |
Preparado de celulase,enzima demonstrando atividade de andoglucanase,enzima de endoglucanase,construcao de dna,vetor de expressao celula,processo para produzir uma enzima de endoglucanase,aditivo composicao detergente,e processo para reduzir a taxa em que os tecidos contendo celulose,se tornam asperos,prover clareamento da cor de tecidos contendo celulose colorida,prover uma variacao localizada da cor de tecidos contendo colorida,e melhorar as propriedades de drenagem de polpa
|
GB9107305D0
(en)
|
1991-04-08 |
1991-05-22 |
Unilever Plc |
Probiotic
|
US5443951A
(en)
|
1992-07-20 |
1995-08-22 |
Kabushiki Kaisha Yakult Honsha |
Species-specific oligonucleotides for bifidobacteria and a method of detection using the same
|
JPH08504327A
(ja)
|
1992-12-10 |
1996-05-14 |
ギスト ブロカデス ナムローゼ フェンノートシャップ |
糸状菌における異種タンパクの生産
|
US5741665A
(en)
|
1994-05-10 |
1998-04-21 |
University Of Hawaii |
Light-regulated promoters for production of heterologous proteins in filamentous fungi
|
AUPM823094A0
(en)
|
1994-09-16 |
1994-10-13 |
Goodman Fielder Limited |
Probiotic compositions
|
RU2078815C1
(ru)
|
1995-01-17 |
1997-05-10 |
Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского |
Штамм бактерий bifidobacterium breve, используемый для получения бактерийных лечебно-профилактических бифидосодержащих препаратов
|
JPH08259450A
(ja)
|
1995-03-17 |
1996-10-08 |
Nichinichi Seiyaku Kk |
インターフェロン産生増強剤
|
US6861053B1
(en)
|
1999-08-11 |
2005-03-01 |
Cedars-Sinai Medical Center |
Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
|
AUPN698495A0
(en)
|
1995-12-06 |
1996-01-04 |
Pharma Pacific Pty Ltd |
Improved therapeutic formulation and method
|
SE508045C2
(sv)
|
1996-02-26 |
1998-08-17 |
Arla Ekonomisk Foerening |
Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
|
JP4282763B2
(ja)
|
1996-03-20 |
2009-06-24 |
ザ、ユニバーシティ、オブ、ニュー、サウス、ウェイルズ |
消化管内の微生物個体数の変更
|
JP4263241B2
(ja)
|
1996-03-27 |
2009-05-13 |
ノボザイムス アクティーゼルスカブ |
アルカリプロテアーゼを欠失した糸状真菌
|
US6033864A
(en)
|
1996-04-12 |
2000-03-07 |
The Regents Of The University Of California |
Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
|
WO1998043081A1
(en)
|
1997-03-26 |
1998-10-01 |
Ligand Pharmaceuticals Incorporated |
Treatment of gastrointestinal disease with ppar modulators
|
SE511524C2
(sv)
|
1997-06-02 |
1999-10-11 |
Essum Ab |
Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
|
US5925657A
(en)
|
1997-06-18 |
1999-07-20 |
The General Hospital Corporation |
Use of PPARγ agonists for inhibition of inflammatory cytokine production
|
AUPO758297A0
(en)
|
1997-06-27 |
1997-07-24 |
Rowe, James Baber |
Control of acidic gut syndrome
|
US5951977A
(en)
|
1997-10-14 |
1999-09-14 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Competitive exclusion culture for swine
|
IT1298918B1
(it)
|
1998-02-20 |
2000-02-07 |
Mendes Srl |
Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
|
DE19826928A1
(de)
|
1998-06-17 |
1999-12-23 |
Novartis Consumer Health Gmbh |
Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
|
ID29150A
(id)
|
1999-01-15 |
2001-08-02 |
Entpr Ireland Cs |
Penggunaan lactobacillus salivarius
|
US7090973B1
(en)
|
1999-04-09 |
2006-08-15 |
Oscient Pharmaceuticals Corporation |
Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics
|
WO2001016120A1
(en)
|
1999-08-27 |
2001-03-08 |
Eli Lilly And Company |
Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
|
AU781415B2
(en)
|
2000-02-08 |
2005-05-19 |
Dsm Ip Assets B.V. |
Use of acid-stable proteases in animal feed
|
FR2808689B1
(fr)
|
2000-05-11 |
2004-09-03 |
Agronomique Inst Nat Rech |
Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs
|
US20020013270A1
(en)
|
2000-06-05 |
2002-01-31 |
Bolte Ellen R. |
Method for treating a mental disorder
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
DE10101793A1
(de)
|
2001-01-17 |
2002-08-01 |
Manfred Nilius |
Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen
|
EP1227152A1
(en)
|
2001-01-30 |
2002-07-31 |
Société des Produits Nestlé S.A. |
Bacterial strain and genome of bifidobacterium
|
KR100437497B1
(ko)
|
2001-03-07 |
2004-06-25 |
주식회사 프로바이오닉 |
로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
|
ATE463505T1
(de)
|
2001-04-20 |
2010-04-15 |
Inst Systems Biology |
Toll-ähnlichen-rezeptor-5-liganden und verwendungsverfahren
|
EP1260227A1
(en)
|
2001-05-23 |
2002-11-27 |
Societe Des Produits Nestle S.A. |
Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
|
US20030092163A1
(en)
|
2001-07-26 |
2003-05-15 |
Collins John Kevin |
Probiotic bifidobacterium strains
|
CA2457092A1
(en)
|
2001-09-05 |
2003-03-20 |
Vsl Pharmaceuticals, Inc. |
Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
|
GB0127916D0
(en)
|
2001-11-21 |
2002-01-16 |
Rowett Res Inst |
Method
|
WO2003045317A2
(en)
|
2001-11-27 |
2003-06-05 |
Washington University |
Therapeutic protein and treatments
|
ES2405405T3
(es)
|
2001-12-17 |
2013-05-31 |
Corixa Corporation |
Composiciones y procedimientos para la terapia y el diagnóstico de enfermedad inflamatoria del intestino
|
DE10206995B4
(de)
|
2002-02-19 |
2014-01-02 |
Orthomol Pharmazeutische Vertriebs Gmbh |
Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
|
JP2003261453A
(ja)
|
2002-03-11 |
2003-09-16 |
Nippon Berumu Kk |
E.フェカリスからなる抗腫瘍剤及び放射線防護剤
|
AU2003242763B2
(en)
|
2002-06-28 |
2008-02-21 |
Biosearch, S.A. |
Probiotic strains, a process for the selection of them, compositions thereof, and their use
|
EP1481681A1
(en)
|
2003-05-30 |
2004-12-01 |
Claudio De Simone |
Lactic acid bacteria combination and compositions thereof
|
WO2005007834A1
(en)
|
2003-07-23 |
2005-01-27 |
Probionic Corp. |
Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
|
US7485325B2
(en)
|
2003-08-06 |
2009-02-03 |
Gayle Dorothy Swain |
Animal food supplement compositions and methods of use
|
JP4683881B2
(ja)
|
2003-08-27 |
2011-05-18 |
有限会社アーク技研 |
抗腫瘍活性剤
|
US8192733B2
(en)
|
2003-08-29 |
2012-06-05 |
Cobb & Associates |
Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions
|
WO2005030133A2
(en)
|
2003-09-22 |
2005-04-07 |
Yale University |
Treatment with agonists of toll-like receptors
|
GB0323039D0
(en)
|
2003-10-01 |
2003-11-05 |
Danisco |
Method
|
CA2543626C
(en)
|
2003-10-24 |
2013-08-27 |
N.V. Nutricia |
Synbiotic composition for infants
|
CA2550106A1
(en)
|
2003-12-17 |
2005-06-30 |
N.V. Nutricia |
Lactic acid producing bacteria and lung function
|
ES2235642B2
(es)
|
2003-12-18 |
2006-03-01 |
Gat Formulation Gmbh |
Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos.
|
EP1727894A1
(en)
|
2004-03-22 |
2006-12-06 |
Government of the United States of America as represented by The Secretary of the Department of Health and Human Services |
Cellular and viral inactivation
|
JP2007535924A
(ja)
|
2004-05-07 |
2007-12-13 |
− グスタフ ユングレン、ハンス |
ワクチン用アジュバントとしてのフラジェリンの使用
|
DE602004006258T3
(de)
|
2004-08-24 |
2013-08-29 |
Nutricia N.V. |
Nahrungszusammensetzung die unverdauliche Transgalaktooligosaccharide sowie verdauliche Galaktose-Saccharide enthält
|
US20060062773A1
(en)
|
2004-09-21 |
2006-03-23 |
The Procter & Gamble Company |
Compositions for maintaining and restoring normal gastrointestinal flora
|
KR100468522B1
(ko)
|
2004-10-12 |
2005-01-31 |
주식회사 프로바이오닉 |
코로나바이러스와 돼지 써코바이러스 2형의 생육을 억제하는 신규한 내산성 프로바이오틱 엔테로코커스훼시움 프로바이오-63
|
ITMI20042189A1
(it)
|
2004-11-16 |
2005-02-16 |
Anidral Srl |
Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
|
CN104223094A
(zh)
|
2005-02-28 |
2014-12-24 |
纽崔西亚公司 |
具有益生菌的营养组合物
|
EP1861490A4
(en)
|
2005-03-23 |
2010-11-17 |
Univ St Louis |
USE OF ARRAYS TO MODULATE NUTRIENT CAPTURE FUNCTIONS BY THE GASTROINTESTINAL MICROBIOTE
|
WO2006102536A2
(en)
|
2005-03-23 |
2006-09-28 |
University Of Southern California |
Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
|
JP2006265212A
(ja)
|
2005-03-25 |
2006-10-05 |
Institute Of Physical & Chemical Research |
Il−21産生誘導剤
|
EP1714660A1
(en)
|
2005-04-21 |
2006-10-25 |
N.V. Nutricia |
Uronic acid and probiotics
|
EP1874917B1
(en)
|
2005-04-26 |
2012-03-14 |
TEAGASC, The Agriculture and Food Development Authority |
Probiotic composition suitable for animals
|
US7572474B2
(en)
|
2005-06-01 |
2009-08-11 |
Mead Johnson Nutrition Company |
Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
|
US8075934B2
(en)
|
2008-10-24 |
2011-12-13 |
Mead Johnson Nutrition Company |
Nutritional composition with improved digestibility
|
JP2007084533A
(ja)
|
2005-08-24 |
2007-04-05 |
Prima Meat Packers Ltd |
免疫応答調節組成物及び該組成物を有効成分とする食品
|
US7625704B2
(en)
|
2005-08-31 |
2009-12-01 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for identifying bacteria associated with bacteria vaginosis
|
AU2006284841B2
(en)
|
2005-09-01 |
2012-11-08 |
Merck Sharp & Dohme Corp. |
Use of IL-23 and IL-17 antagonists to treat autoimmune ocular inflammatory disease
|
WO2007035057A1
(en)
|
2005-09-23 |
2007-03-29 |
Gwangju Institute Of Science And Technology |
Composition for preventing or treating artritis comprising lactic acid bacteria and collangen as active ingredients
|
EP1776877A1
(en)
|
2005-10-21 |
2007-04-25 |
N.V. Nutricia |
Method for stimulating the intestinal flora
|
CN103211230A
(zh)
|
2005-10-24 |
2013-07-24 |
雀巢技术公司 |
膳食纤维制剂和施用方法
|
JP2007116991A
(ja)
|
2005-10-28 |
2007-05-17 |
Eternal Light General Institute Inc |
機能性食品
|
US8889149B2
(en)
|
2006-02-16 |
2014-11-18 |
Wayne State University |
Use of flagellin to prevent and treat gram negative bacterial infection
|
JP5031249B2
(ja)
|
2006-03-22 |
2012-09-19 |
学校法人北里研究所 |
炎症抑制作用のある菌体含有組成物
|
CA2652559A1
(en)
|
2006-05-18 |
2007-11-29 |
Biobalance Llc |
Biotherapeutic compositions and uses thereof
|
JP2009538342A
(ja)
|
2006-05-26 |
2009-11-05 |
ネステク ソシエテ アノニム |
トウチ抽出物の使用方法及び栄養組成物
|
ES2525223T3
(es)
|
2006-08-04 |
2014-12-19 |
Shs International Ltd. |
Fórmula sin proteínas
|
WO2008031438A2
(en)
|
2006-09-13 |
2008-03-20 |
Region Hovedstaden V/Gentofte Hospital |
Treatment of asthma, eczema and/or allergy using non-pathogenic organisms
|
US20080069861A1
(en)
|
2006-09-19 |
2008-03-20 |
National Starch And Chemical Investment Holding Corporation |
Probiotic/Non-Probiotic Combinations
|
US20100168410A1
(en)
|
2006-10-27 |
2010-07-01 |
Pfizer Products Inc. |
Hydroxypropyl Methyl Cellulose Hard Capsules and Process of Manufacture
|
WO2008053444A2
(en)
|
2006-11-01 |
2008-05-08 |
The Procter & Gamble Company |
Treating a respiratory condition with bifidobacterium
|
EP1920781B1
(en)
|
2006-11-10 |
2015-03-04 |
Glycotope GmbH |
Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors
|
WO2008064489A1
(en)
|
2006-12-01 |
2008-06-05 |
Mcmaster University |
Probiotics to inhibit inflammation
|
DE102006062250A1
(de)
|
2006-12-22 |
2008-06-26 |
Roland Saur-Brosch |
Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden
|
JP2008195635A
(ja)
|
2007-02-09 |
2008-08-28 |
Crossfield Bio Inc |
馬用乳酸菌製剤
|
PL2114423T3
(pl)
|
2007-02-28 |
2012-10-31 |
Mjn Us Holdings Llc |
Produkt zawierający unieczynniony probiotyk dla niemowląt
|
US8557233B2
(en)
|
2007-03-28 |
2013-10-15 |
Alimentary Heath Limited |
Probiotic bifidobacterium strains
|
BRPI0809448A2
(pt)
|
2007-03-28 |
2014-09-09 |
Alimentary Health Ltd |
Cepas de bifidobacterium probióticas
|
EP2147091A4
(en)
|
2007-04-24 |
2010-12-08 |
Kemin Ind Inc |
ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY WITH LACTOBACILLUS JOHNSONII D115 LARGE SPECTRUM
|
EP1997499A1
(en)
|
2007-05-31 |
2008-12-03 |
Puleva Biotech, S.A. |
Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
|
EP1997905A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Nucleic acid amplification
|
EP1997906A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Lactobacillus
|
EP1997907A1
(en)
|
2007-06-01 |
2008-12-03 |
Friesland Brands B.V. |
Bifidobacteria
|
WO2008153377A1
(en)
|
2007-06-15 |
2008-12-18 |
N.V. Nutricia |
Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
|
EP2522358B1
(en)
|
2007-06-27 |
2016-11-09 |
Laboratorios Ordesa, S.l. |
Peptides against rotavirus infection
|
HUP0700552A2
(en)
|
2007-08-27 |
2009-03-30 |
Janos Dr Feher |
Method and composition inhibiting inflammation
|
WO2009030254A1
(en)
|
2007-09-04 |
2009-03-12 |
Curevac Gmbh |
Complexes of rna and cationic peptides for transfection and for immunostimulation
|
WO2009043856A2
(en)
|
2007-10-01 |
2009-04-09 |
University College Cork, National University Of Ireland, Cork |
Modulation of tissue fatty acid composition of a host by human gut bacteria
|
JP5327984B2
(ja)
|
2007-10-20 |
2013-10-30 |
ユニベルシテ・ド・リエージュ |
ビフィズス菌の種
|
NZ585210A
(en)
|
2007-10-26 |
2012-07-27 |
Brenda e moore |
Probiotic compositions comprising bacteroides and methods for inducing and supporting weight loss
|
EP2065048A1
(en)
|
2007-11-30 |
2009-06-03 |
Institut Pasteur |
Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
|
CN103263443B
(zh)
|
2007-12-07 |
2016-09-14 |
努特里希亚公司 |
用于尘螨变态反应的双歧杆菌
|
WO2009079564A2
(en)
|
2007-12-17 |
2009-06-25 |
Emory University |
Immunogenic compositions and methods of use thereof
|
US20090196921A1
(en)
|
2008-02-06 |
2009-08-06 |
The Procter & Gamble Company |
Compositions Methods and Kits For Enhancing Immune Response To A Respiratory Condition
|
JP2011519828A
(ja)
|
2008-04-18 |
2011-07-14 |
バクシネート コーポレーション |
フラジェリンの欠失変異体と使用方法
|
MX2008006546A
(es)
|
2008-05-21 |
2009-11-23 |
Sigma Alimentos Sa De Cv |
Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria.
|
CN102940652B
(zh)
|
2008-05-28 |
2015-03-25 |
青岛东海药业有限公司 |
两形真杆菌制剂及其应用
|
CN101590081A
(zh)
|
2008-05-28 |
2009-12-02 |
青岛东海药业有限公司 |
凸腹真杆菌和两形真杆菌制剂及其应用
|
US8586029B2
(en)
|
2008-06-04 |
2013-11-19 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
EP2133088A3
(en)
|
2008-06-09 |
2010-01-27 |
Nestec S.A. |
Rooibos and inflammation
|
WO2009151315A1
(en)
|
2008-06-13 |
2009-12-17 |
N.V. Nutricia |
Nutritional composition for infants delivered via caesarean section
|
WO2009154463A2
(en)
|
2008-06-20 |
2009-12-23 |
Stichting Top Institute Food And Nutrition |
Butyrate as a medicament to improve visceral perception in humans
|
EP2138186A1
(en)
|
2008-06-24 |
2009-12-30 |
Nestec S.A. |
Probiotics, secretory IgA and inflammation
|
WO2010002241A1
(en)
|
2008-06-30 |
2010-01-07 |
N.V. Nutricia |
Nutritional composition for infants delivered via caesarean section
|
KR101017448B1
(ko)
|
2008-09-18 |
2011-02-23 |
주식회사한국야쿠르트 |
대장의 건강 증진 효능을 갖는 비피도박테리움 롱검 에이취와이8004 및 이를 유효성분으로 함유하는 제품
|
US8137718B2
(en)
|
2008-09-19 |
2012-03-20 |
Mead Johnson Nutrition Company |
Probiotic infant products
|
US20100074870A1
(en)
|
2008-09-19 |
2010-03-25 |
Bristol-Myers Squibb Company |
Probiotic infant products
|
KR101057357B1
(ko)
|
2008-09-22 |
2011-08-17 |
광주과학기술원 |
유산균 및 콜라겐을 유효성분으로 포함하는 관절염 예방 또는 치료용 약제학적 조성물 및 식품 조성물
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
AU2009321592B2
(en)
|
2008-12-05 |
2014-12-04 |
Nestec S.A. |
Compositions for use in low-birth weight infants
|
CA2746805A1
(en)
|
2008-12-19 |
2010-06-24 |
Nestec S.A. |
Prevention and treatment of rotavirus diarrhoea
|
IT1392672B1
(it)
|
2009-01-12 |
2012-03-16 |
Wyeth Consumer Healthcare S P A |
Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
|
US8835610B2
(en)
|
2009-03-05 |
2014-09-16 |
Abbvie Inc. |
IL-17 binding proteins
|
JP5710876B2
(ja)
|
2009-03-26 |
2015-04-30 |
クロスフィールドバイオ株式会社 |
新規ビフィドバクテリウム属微生物およびその利用
|
US8816067B2
(en)
|
2009-05-07 |
2014-08-26 |
Tate & Lyle Ingredients France SAS |
Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
|
EP2251022A1
(en)
|
2009-05-11 |
2010-11-17 |
Nestec S.A. |
Non-replicating micro-organisms and their immune boosting effect
|
EP2251020A1
(en)
|
2009-05-11 |
2010-11-17 |
Nestec S.A. |
Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
|
MY165388A
(en)
|
2009-05-11 |
2018-03-21 |
Nestec Sa |
Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
|
KR20100128168A
(ko)
|
2009-05-27 |
2010-12-07 |
중앙대학교 산학협력단 |
공액 리놀레산 생산능이 우수한 신규한 균주
|
US20100311686A1
(en)
|
2009-06-03 |
2010-12-09 |
Kasper Lloyd H |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
WO2010143940A1
(en)
|
2009-06-12 |
2010-12-16 |
N.V. Nutricia |
Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
|
EP2443259A4
(en)
|
2009-06-16 |
2012-10-10 |
Univ Columbia |
BIOMARKERS FOR AUTISM AND USES THEREOF
|
WO2011005756A1
(en)
|
2009-07-06 |
2011-01-13 |
Puretech Ventures, Llc |
Delivery of agents targeted to microbiota niches
|
MY163002A
(en)
|
2009-08-18 |
2017-07-31 |
Nestec Sa |
A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
WO2011036539A1
(en)
|
2009-09-23 |
2011-03-31 |
Borody Thomas J |
Therapy for enteric infections
|
EP2308498A1
(en)
|
2009-09-30 |
2011-04-13 |
Nestec S.A. |
Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
|
EP2486143A1
(en)
|
2009-10-05 |
2012-08-15 |
AAK Patent B.V. |
Methods for diagnosing irritable bowel syndrome
|
EP2485742A4
(en)
|
2009-10-06 |
2013-03-20 |
Scott Dorfner |
ANTIBIOTIC FORMULATIONS WITH REDUCED SIDE EFFECTS ON STOMACH AND DARM
|
RU2546251C2
(ru)
|
2009-11-11 |
2015-04-10 |
Алиментари Хелс Лимитед |
Пробиотический штамм бифидобактерий
|
US20150104418A1
(en)
|
2014-12-18 |
2015-04-16 |
Microbios, Inc. |
Bacterial composition
|
FR2955774A1
(fr)
|
2010-02-02 |
2011-08-05 |
Aragan |
Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
|
NL2004200C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides in weight management.
|
NL2004201C2
(en)
|
2010-02-05 |
2011-08-08 |
Friesland Brands Bv |
Use of sialyl oligosaccharides to modulate the immune system.
|
IT1398553B1
(it)
|
2010-03-08 |
2013-03-01 |
Probiotical Spa |
Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
|
JP5737646B2
(ja)
|
2010-03-24 |
2015-06-17 |
森下仁丹株式会社 |
抗アレルギー剤
|
EP2552464B1
(en)
|
2010-03-30 |
2018-02-28 |
Assistance Publique - Hôpitaux de Paris |
Use of bifidobacteria for preventing allergy in breastfed infants
|
WO2011149335A1
(en)
|
2010-05-25 |
2011-12-01 |
N.V. Nutricia |
Immune imprinting nutritional composition
|
AU2011261528A1
(en)
|
2010-06-01 |
2013-01-10 |
Moore Research Enterprises Llc |
Cellular constituents from Bacteroides, compositions thereof, and therapeutic methods employing Bacteroides or cellular constituents thereof
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性t細胞の増殖または集積を誘導する作用を有する組成物
|
TWI417054B
(zh)
|
2010-06-15 |
2013-12-01 |
Jen Shine Biotechnology Co Ltd |
新穎糞腸球菌ljs-01及其益生用途
|
EP2397145A1
(en)
|
2010-06-18 |
2011-12-21 |
Nestec S.A. |
L. johnsonii La1, B. longum NCC2705 and immune disorders
|
FR2962045B1
(fr)
|
2010-07-05 |
2012-08-17 |
Bifinove |
Complexe macromoleculaire d'origine bacterienne et utilisation dudit complexe moleculaire pour prevenir et traiter les rhumatismes inflammatoires
|
TWI401086B
(zh)
|
2010-07-20 |
2013-07-11 |
Univ China Medical |
胚芽乳酸桿菌及其用途
|
WO2012024638A2
(en)
|
2010-08-20 |
2012-02-23 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
KR101250463B1
(ko)
|
2010-10-12 |
2013-04-15 |
대한민국 |
신생아 분변에서 분리한 내산소성 비피도박테리움 롱검 비피더스 유산균 및 이를 이용한 프로바이오틱 조성물
|
CN102031235B
(zh)
|
2010-11-09 |
2012-07-25 |
中国农业大学 |
一种粪肠球菌anse228及其应用
|
EP2455092A1
(en)
|
2010-11-11 |
2012-05-23 |
Nestec S.A. |
Non-replicating probiotic micro-organisms protect against upper respiratory tract infections
|
WO2012071380A1
(en)
|
2010-11-24 |
2012-05-31 |
Oragenics, Inc. |
Use of bacteria to treat and prevent respiratory infections
|
CN102093967B
(zh)
|
2010-12-02 |
2013-01-30 |
中国农业科学院特产研究所 |
一株水貂源屎肠球菌及其应用
|
ES2389547B1
(es)
|
2010-12-07 |
2013-08-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
|
KR20140030132A
(ko)
|
2011-01-10 |
2014-03-11 |
클리브랜드 바이오랩스, 아이엔씨. |
암을 치료하기 위한 톨-유사 수용체 효능제의 용도
|
ES2610908T3
(es)
|
2011-01-31 |
2017-05-04 |
Synformulas Gmbh |
Cepas de bifidobacterium bifidum para su aplicación en enfermedades gastrointestinales
|
JP5840368B2
(ja)
|
2011-02-02 |
2016-01-06 |
カルピス株式会社 |
関節炎予防改善用物質
|
LT2672980T
(lt)
|
2011-02-09 |
2018-03-12 |
Lavivo Ab |
Simbiozinės kompozicijos žarnyno mikrobiotos atkūrimui ir rekonstrukcijai
|
BRPI1100857A2
(pt)
|
2011-03-18 |
2013-05-21 |
Alexandre Eduardo Nowill |
agente imunomodulador e suas combinaÇÕes, seu uso e mÉtodo imunoterÁpico para a recontextualizaÇço, reprogramaÇço e reconduÇço do sistema imune em tempo real
|
WO2012140636A1
(en)
|
2011-04-11 |
2012-10-18 |
Alimentary Health Limited |
A probiotic formulation
|
WO2012142605A1
(en)
|
2011-04-15 |
2012-10-18 |
Samaritan Health Services |
Rapid recolonization deployment agent
|
BR112013026929A2
(pt)
|
2011-04-20 |
2016-12-27 |
Mico Bio Inc |
composição e método para intensificação de uma resposta imune
|
WO2012158517A1
(en)
|
2011-05-13 |
2012-11-22 |
Glycosyn LLC |
The use of purified 2'-fucosyllactose, 3-fucosyllactose and lactodifucotetraose as prebiotics
|
KR20120133133A
(ko)
|
2011-05-30 |
2012-12-10 |
한국 한의학 연구원 |
생약 추출물 또는 이의 유산균 발효물을 포함하는 호흡기 질환의 예방 또는 치료용 조성물
|
GB201110095D0
(en)
|
2011-06-15 |
2011-07-27 |
Danisco |
Method of treatment
|
JP2013005759A
(ja)
|
2011-06-24 |
2013-01-10 |
Kyodo Milk Industry Co Ltd |
マウス腸内菌叢の推測方法
|
WO2013005836A1
(ja)
|
2011-07-07 |
2013-01-10 |
長岡香料株式会社 |
フルクトース吸収阻害剤
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
US20130022575A1
(en)
|
2011-07-19 |
2013-01-24 |
Microbial Rx |
Systems and methods of replacing intestinal flora
|
CN102304483A
(zh)
|
2011-08-12 |
2012-01-04 |
北京金泰得生物科技股份有限公司 |
一株饲用屎肠球菌及其应用
|
KR101261872B1
(ko)
|
2011-08-23 |
2013-05-14 |
대한민국 (식품의약품안전처장) |
장내 미생물 효소복합체 및 이의 제조방법
|
US20140342438A1
(en)
|
2011-09-14 |
2014-11-20 |
University Of Guelph |
Media supplements and methods to culture human gastrointestinal anaerobic microorganisms
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
CN103857402A
(zh)
|
2011-10-11 |
2014-06-11 |
阿基姆医药公司 |
包括厌氧培养的人类肠道微生物群的组合物
|
CN103082292B
(zh)
|
2011-11-02 |
2015-03-04 |
深圳华大基因研究院 |
罗斯氏菌(Roseburia)在治疗和预防肥胖相关疾病中的应用
|
CN102373172B
(zh)
|
2011-11-03 |
2013-03-20 |
北京龙科方舟生物工程技术有限公司 |
一株屎肠球菌及其应用
|
CN108676774B
(zh)
|
2011-12-01 |
2023-05-09 |
国立大学法人东京大学 |
诱导调节性t细胞的增殖或积累的人源细菌
|
ES2408279B1
(es)
|
2011-12-15 |
2014-09-09 |
Universidad De Las Palmas De Gran Canaria |
Bacteria acido láctica probiótica
|
ITBG20120010A1
(it)
|
2012-02-24 |
2013-08-25 |
Milano Politecnico |
Dispositivo per l'addestramento chirurgico
|
ITMI20120471A1
(it)
|
2012-03-26 |
2013-09-27 |
Giovanni Mogna |
Composizione a base di ceppi di batteri bifidobacterium longum in grado di aiutare il prolungamento della vita
|
JP5792105B2
(ja)
|
2012-03-27 |
2015-10-07 |
森永乳業株式会社 |
ラクト−n−ビオースiの製造方法
|
WO2013146319A1
(ja)
|
2012-03-30 |
2013-10-03 |
味の素株式会社 |
糖尿病誘起細菌
|
WO2013154826A2
(en)
|
2012-04-11 |
2013-10-17 |
Nestec Sa |
Methods for diagnosing impending diarrhea
|
JP2015512936A
(ja)
|
2012-04-13 |
2015-04-30 |
トラスティーズ オブ ボストン カレッジ |
プレバイオティクス組成物およびその使用方法
|
GB201206599D0
(en)
|
2012-04-13 |
2012-05-30 |
Univ Manchester |
Probiotic bacteria
|
NZ703394A
(en)
|
2012-06-04 |
2017-01-27 |
Centre For Digestive Diseases |
Compositions and methods for treating crohn’s disease and related conditions and infections
|
US9676847B2
(en)
|
2012-06-25 |
2017-06-13 |
Orega Biotech |
IL-17 antagonist antibodies
|
US9561194B2
(en)
|
2012-07-31 |
2017-02-07 |
Nestec S.A. |
Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (IBD)
|
CN114949001A
(zh)
|
2012-08-29 |
2022-08-30 |
加州理工学院 |
孤独症谱系障碍的诊断和治疗
|
EP2890367A4
(en)
|
2012-08-29 |
2016-03-30 |
Salix Pharmaceuticals Inc |
REMEDY COMPOSITION AND METHOD FOR TREATING CONSTELLATION AND RELATED DISEASES AND SUFFERING THE STOMACH DARM TRAKT
|
WO2014043593A2
(en)
|
2012-09-13 |
2014-03-20 |
Massachusetts Institute Of Technology |
Programmable drug delivery profiles of tumor-targeted bacteria
|
KR101473058B1
(ko)
|
2012-09-19 |
2014-12-16 |
주식회사 쎌바이오텍 |
과민성 대장 증후군 예방 또는 치료용 조성물
|
CN103652322B
(zh)
|
2012-09-21 |
2016-02-10 |
临沂思科生物科技有限公司 |
一种含乳酸菌的复合益生菌饲料添加剂的制备方法
|
FR2997091B1
(fr)
|
2012-10-22 |
2016-05-06 |
Fond Mediterranee Infection |
Utilisation d'un compose antioxydant pour la culture de bacteries sensibles a la tension en oxygene
|
US9839657B2
(en)
|
2012-10-30 |
2017-12-12 |
Deerland Enzymes, Inc. |
Prebiotic compositions comprising one or more types of bacteriophage
|
CN104755092A
(zh)
|
2012-10-30 |
2015-07-01 |
雀巢产品技术援助有限公司 |
用于递送协同免疫作用的包含微粒和益生菌的组合物
|
WO2014075745A1
(en)
|
2012-11-19 |
2014-05-22 |
Université Catholique de Louvain |
Use of akkermansia for treating metabolic disorders
|
KR102617655B1
(ko)
|
2012-11-23 |
2023-12-27 |
세레스 테라퓨틱스, 인코포레이티드 |
상승작용적 박테리아 조성물, 그리고 이의 제조 방법 및 용도
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
CA2896795A1
(en)
|
2012-11-26 |
2014-05-30 |
Thomas Julius Borody |
Compositions for the restoration of a fecal microbiota and methods for making and using them
|
US20140193464A1
(en)
|
2013-01-08 |
2014-07-10 |
Imagilin Technology, Llc |
Effects of probiotics on humans and animals under environmental or biological changes
|
RU2664479C2
(ru)
|
2013-02-04 |
2018-08-17 |
Серес Терапеутикс, Инк. |
Композиции и способы
|
EP2951283A4
(en)
*
|
2013-02-04 |
2017-01-25 |
Seres Therapeutics, Inc. |
Compositions and methods
|
EP2958575B1
(en)
|
2013-02-22 |
2019-04-03 |
The Regents of The University of California |
Composition comprising lactobaccilus johnsonii 456 and its use in treating or preventing diseases
|
KR20150134356A
(ko)
|
2013-03-05 |
2015-12-01 |
리엑스유니버시테이트 그로닝겐 |
염증을 억제하기 위한 페칼리 박테리움 프라우스니치이 htf-f (dsm 26943)의 용도
|
JP6464142B2
(ja)
|
2013-03-14 |
2019-02-06 |
セラバイオーム,エルエルシー |
プロバイオティクス生物及び/又は治療剤の標的化胃腸管デリバリー
|
US20160040215A1
(en)
|
2013-03-14 |
2016-02-11 |
Seres Therapeutics, Inc. |
Methods for Pathogen Detection and Enrichment from Materials and Compositions
|
WO2014145970A1
(en)
|
2013-03-15 |
2014-09-18 |
President And Fellows Of Harvard College |
Modulation of regulatory t cells via g-coupled protein receptor 43
|
EP2967077A4
(en)
|
2013-03-15 |
2016-09-14 |
Seres Therapeutics Inc |
MICROBIAL COMPOSITIONS AND ASSOCIATED METHODS BASED ON A NETWORK
|
WO2014150094A1
(en)
|
2013-03-15 |
2014-09-25 |
University Of Florida Research Foundation, Inc. |
Butyrogenic bacteria as probiotics to treat clostridium difficile
|
CN103142656A
(zh)
|
2013-03-18 |
2013-06-12 |
广州知光生物科技有限公司 |
脆弱拟杆菌在制备防治结肠癌组合物中的应用
|
CN103156888A
(zh)
|
2013-03-18 |
2013-06-19 |
广州知光生物科技有限公司 |
脆弱拟杆菌在制备治疗炎症性肠病组合物中的应用
|
CN103146620A
(zh)
|
2013-03-25 |
2013-06-12 |
广州知光生物科技有限公司 |
具有益生菌特性的脆弱拟杆菌
|
JP2014196260A
(ja)
|
2013-03-29 |
2014-10-16 |
公立大学法人奈良県立医科大学 |
慢性閉塞性肺疾患の予防又は治療用組成物
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
EP2994161B1
(en)
|
2013-05-10 |
2020-10-28 |
California Institute of Technology |
Probiotic prevention and treatment of colon cancer
|
US9511099B2
(en)
|
2013-06-05 |
2016-12-06 |
Rebiotix, Inc. |
Microbiota restoration therapy (MRT), compositions and methods of manufacture
|
HUE040211T2
(hu)
|
2013-06-05 |
2019-02-28 |
Rebiotix Inc |
Mikrobióta-helyreállítási terápia (MRT), készítmények és elõállítási eljárások
|
US20160120915A1
(en)
|
2013-06-10 |
2016-05-05 |
New York University |
Methods for manipulating immune responses by altering microbiota
|
WO2014200334A1
(en)
|
2013-06-14 |
2014-12-18 |
N.V. Nutricia |
Synbiotic composition for treatment of infections in allergic patients
|
WO2015003001A1
(en)
|
2013-07-01 |
2015-01-08 |
The Washington University |
Methods for identifying supplements that increase gut colonization by an isolated bacterial species, and compositions derived therefrom
|
WO2015003305A1
(zh)
|
2013-07-08 |
2015-01-15 |
吉瑞高新科技股份有限公司 |
电子烟盒
|
US9764019B2
(en)
|
2013-07-09 |
2017-09-19 |
Vedanta Biosciences, Inc. |
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
|
JP6637885B2
(ja)
|
2013-07-21 |
2020-01-29 |
ペンデュラム セラピューティクス, インコーポレイテッド |
マイクロバイオームの特性解明、モニタリング、および処置のための方法およびシステム
|
US20160192689A1
(en)
|
2013-07-31 |
2016-07-07 |
Wikifoods, Inc. |
Encapsulated functional food compositions
|
WO2015021936A1
(en)
|
2013-08-16 |
2015-02-19 |
The University Of Hong Kong |
Method and compositions for treating cancer using probiotics cross-reference to related application
|
CN103509741B
(zh)
|
2013-08-22 |
2015-02-18 |
河北农业大学 |
布劳特菌auh-jld56及其在牛蒡苷元转化中的应用
|
US10203329B2
(en)
|
2013-09-12 |
2019-02-12 |
The Johns Hopkins University |
Biofilm formation to define risk for colon cancer
|
ES2785330T3
(es)
|
2013-10-18 |
2020-10-06 |
Innovachildfood Ab |
Comida compuesta nutricionalmente equilibrada para lactantes y niños pequeños y método de producción de dicha comida
|
PL229020B1
(pl)
|
2013-11-13 |
2018-05-30 |
Inst Biotechnologii Surowic I Szczepionek Biomed Spolka Akcyjna |
Nowy szczep Bifidobacterium breve
|
KR102515850B1
(ko)
|
2013-11-25 |
2023-03-30 |
세레스 테라퓨틱스, 인코포레이티드 |
상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
CN103981117B
(zh)
|
2013-12-24 |
2018-10-26 |
北京大伟嘉生物技术股份有限公司 |
一株高抗逆性屎肠球菌及其培养方法和应用
|
CN103981115B
(zh)
|
2013-12-24 |
2018-10-26 |
北京大伟嘉生物技术股份有限公司 |
一株高抗逆性屎肠球菌及其应用
|
CN103820363B
(zh)
|
2014-01-27 |
2016-02-24 |
福建省农业科学院生物技术研究所 |
一种屎肠球菌菌粉的制备与应用
|
CN103865846B
(zh)
|
2014-02-27 |
2016-03-30 |
扬州绿保生物科技有限公司 |
一种屎肠球菌及其制备方法
|
CN103849590B
(zh)
|
2014-03-25 |
2016-07-06 |
上海交通大学 |
一株耐酸短双歧杆菌BB8dpH及其应用
|
KR101683474B1
(ko)
|
2014-03-26 |
2016-12-08 |
주식회사 쎌바이오텍 |
과민성 대장 증후군 예방 또는 치료용 조성물
|
US9783858B2
(en)
|
2014-04-02 |
2017-10-10 |
Northwestern University |
Altered microbiome of chronic pelvic pain
|
KR101583546B1
(ko)
|
2014-04-09 |
2016-01-11 |
국립암센터 |
유전자 다형성을 이용한 소라페닙 치료에 대한 반응성 예측방법
|
CA2944846C
(en)
*
|
2014-04-10 |
2023-01-03 |
Riken |
Compositions and methods for induction of th17 cells
|
CN104195075B
(zh)
|
2014-08-14 |
2017-04-19 |
生合生物科技股份有限公司 |
一种屎肠球菌ef08及包含它的饲料添加物和饲料
|
WO2015168534A1
(en)
|
2014-05-02 |
2015-11-05 |
Novogy, Inc. |
Therapeutic treatment of gastrointestinal microbial imbalances through competitive microbe displacement
|
ES2960598T3
(es)
|
2014-05-08 |
2024-03-05 |
Kiora Pharmaceuticals Gmbh |
Compuestos para el tratamiento de enfermedades y trastornos oftálmicos
|
CN106687130B
(zh)
|
2014-08-05 |
2020-01-21 |
深圳华大基因科技有限公司 |
真杆菌属在预防和治疗结直肠癌相关疾病中的用途
|
WO2016033439A2
(en)
|
2014-08-28 |
2016-03-03 |
Yale University |
Compositions and methods for the treating an inflammatory disease or disorder
|
US20160058808A1
(en)
|
2014-09-03 |
2016-03-03 |
California Institute Of Technology |
Microbe-based modulation of serotonin biosynthesis
|
CN104546934B
(zh)
|
2014-09-30 |
2019-04-09 |
深圳华大基因科技有限公司 |
粪副拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546932A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
卵形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546940A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
平常拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546942A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
多氏拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546935A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
多形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
CN104546933A
(zh)
|
2014-09-30 |
2015-04-29 |
深圳华大基因科技有限公司 |
粪拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
|
US10046030B2
(en)
|
2014-10-07 |
2018-08-14 |
University Of Virginia Patent Foundation |
Compositions and methods for preventing and treating infection
|
CN114376234A
(zh)
|
2014-10-24 |
2022-04-22 |
进化生物系统股份有限公司 |
活化的双歧杆菌及其应用方法
|
US10124025B2
(en)
|
2014-10-30 |
2018-11-13 |
California Institute Of Technology |
Compositions and methods comprising bacteria for improving behavior in neurodevelopmental disorders
|
JP2017535542A
(ja)
|
2014-10-30 |
2017-11-30 |
カリフォルニア インスティチュート オブ テクノロジー |
神経発達症群における行動の改善のための細菌含有組成物、及び細菌を使用することを含む、神経発達症群における行動の改善のための方法
|
CN113730442A
(zh)
|
2014-10-31 |
2021-12-03 |
潘德勒姆治疗公司 |
与病症的微生物治疗和诊断有关的方法和组合物
|
CN104435000A
(zh)
|
2014-11-12 |
2015-03-25 |
江南大学 |
乳酸菌对支气管哮喘治疗中的应用
|
CA2968325A1
(en)
|
2014-11-25 |
2016-06-02 |
Memorial Sloan-Kettering Cancer Center |
Intestinal microbiota and gvhd
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
KR101942955B1
(ko)
|
2014-12-23 |
2019-01-28 |
4디 파마 리서치 리미티드 |
면역 조정
|
KR20170091157A
(ko)
|
2014-12-23 |
2017-08-08 |
4디 파마 리서치 리미티드 |
피린 폴리펩티드 및 면역 조정
|
CN104560820B
(zh)
|
2014-12-30 |
2017-10-20 |
杭州师范大学 |
屎肠球菌kq2.6及应用
|
SG10201907660YA
(en)
|
2015-01-23 |
2019-10-30 |
Univ Temple |
Use of short chain fatty acids in cancer prevention
|
CN105982919A
(zh)
|
2015-02-26 |
2016-10-05 |
王汉成 |
生物减速剂抗癌技术
|
WO2016139217A1
(en)
|
2015-03-04 |
2016-09-09 |
Ab-Biotics, S.A. |
Composition comprising anaerobically cultivated human intestinal microbiota
|
WO2016149449A1
(en)
|
2015-03-18 |
2016-09-22 |
Tufts University |
Compositions and methods for preventing colorectal cancer
|
EP3270938A4
(en)
|
2015-03-18 |
2018-12-19 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of skin disorders
|
KR20180011262A
(ko)
|
2015-06-01 |
2018-01-31 |
더 유니버서티 오브 시카고 |
공생 미생물총의 조작에 의한 암의 치료
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
AU2016278067B2
(en)
|
2015-06-15 |
2022-09-22 |
Cj Bioscience, Inc. |
Compositions comprising bacterial strains
|
MX2017016529A
(es)
|
2015-06-15 |
2018-03-12 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas.
|
ES2742514T3
(es)
|
2015-06-15 |
2020-02-14 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
EA201890097A1
(ru)
|
2015-06-22 |
2018-07-31 |
Президент Энд Феллоуз Оф Гарвард Колледж |
Индукция регуляторных т-клеток lamina propria
|
CN105112333A
(zh)
|
2015-08-31 |
2015-12-02 |
江南大学 |
一种具有良好肠道定殖能力的长双歧杆菌及筛选方法和应用
|
LT3209310T
(lt)
|
2015-11-20 |
2018-04-25 |
4D Pharma Research Limited |
Kompozicijos, apimančios bakterinius kamienus
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
EP3379935A4
(en)
|
2015-11-25 |
2019-08-28 |
Memorial Sloan-Kettering Cancer Center |
METHOD AND COMPOSITIONS FOR REDUCING VANCOMYCIN RESISTANT ENTEROKOKKEN
|
DK3313423T3
(da)
|
2016-03-04 |
2019-05-20 |
4D Pharma Plc |
Sammensætninger omfattende bakterielle blautia-stammer til behandling af visceral hypersensitivitet
|
TW201821093A
(zh)
|
2016-07-13 |
2018-06-16 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
WO2018112365A2
(en)
|
2016-12-16 |
2018-06-21 |
Evelo Biosciences, Inc. |
Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii
|
US20190314427A1
(en)
|
2016-12-16 |
2019-10-17 |
Evelo Biosciences, Inc. |
Methods of treating cancer using parabacteroides
|